Arcellx (ACLX)

• Market cap: $4.89B
• 1 day: 0.79%
• 5 days: 0.74%
• 1 month: 4.53%
• 3 months: 24.81%
• 6 months: 67.05%
• Year to date: 12%
• 1 year: -5.14%
• 5 years: 425%
• 10 years: 425%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163